FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSightâ„¢ CNV Analysis - a whole genome-based test for the detection of ...
A retrospective Chinese study of 472 fetuses with non-structural ultrasound abnormalities in pregnant women under 35 found ...
Microarrays are an important tool for the research and analysis of genomic copy number alterations in various human cancers. In recent years, the use of microarrays has been integrated into the ...
A ten-year study of 849 pregnancy loss samples demonstrates that chromosomal microarray testing detects genetic abnormalities in over sixty-two percent of cases, with risk rising steeply alongside ...